Form 8-K - Current report:
SEC Accession No. 0001193125-25-325856
Filing Date
2025-12-19
Accepted
2025-12-19 08:47:02
Documents
16
Period of Report
2025-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d49247d8k.htm   iXBRL 8-K 56211
2 EX-2.1 d49247dex21.htm EX-2.1 597666
3 EX-99.1 d49247dex991.htm EX-99.1 48268
7 GRAPHIC g49247dsp1.jpg GRAPHIC 6677
8 GRAPHIC g49247dsp1a.jpg GRAPHIC 7294
  Complete submission text file 0001193125-25-325856.txt   1012692

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20251219.xsd EX-101.SCH 2852
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20251219_lab.xml EX-101.LAB 17234
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20251219_pre.xml EX-101.PRE 10813
19 EXTRACTED XBRL INSTANCE DOCUMENT d49247d8k_htm.xml XML 3532
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 251585255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)